Добро пожаловать
Зарегистрировать аккаунт
Войдите, используя email
Зарегистрируйтесь с помощью email
Проверь свои входящие
EndoStim
About
EndoStim is a medical device company developing therapeutics for gastrointestinal and urological neuro-muscular disorders.
- St Louis,Missouri,United States
- 1 - 10
Details
- Last Funding Type
- Series D
- Last Funding Money Raised
- $14.10M
- Industries
- Biotechnology,Medical,Medical Device,Therapeutics
- Founded date
- Jan 1, 2009
- Number Of Employee
- 1 - 10
- Operating Status
- Active
- Legal Name
- EndoStim, Inc.
EndoStim is a medical device company developing therapeutics for gastrointestinal and urological neuro-muscular disorders. It is performing clinical trials to pursue FDA approval for a new treatment for sphincter-related disorders such as gastroesophageal reflux disease (GERD) and urinary urge incontinence. Its microstimulator technology provides long-term reflux control by restoring normal esophageal function that directly targets the patient's weak or dysfunctional lower esophageal sphincter (LES) muscle between the stomach and the esophagus and enable patients to reduce or avoid typical gastrointestinal side effects of traditional anti-reflux surgery.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 16, 2018 | Series E | $12.14M | — | — | — | Detail |
| May 12, 2016 | Series D | $25M | 4 |
Endeavour Vision
Sante Ventures
|
— | Detail |
| Jul 10, 2014 | Debt Financing | $6.36M | — | — | — | Detail |
| Jun 5, 2013 | Series D | $14.10M | 3 | — | — | Detail |
| Jan 14, 2013 | Series C | $9.13M | 3 | — | — | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Endeavour Vision
|
Yes | Series D |
|
Sante Ventures
|
Yes | Series D |
|
|
— | Series D |
Wellington Partners
|
— | Series D |
|
|
— | Series D |
Prolog Ventures
|
— | Series D |
Billiken Angels Network
|
— | Series C |
|
|
— | Series B |
Employee Profiles
